Detalhe da pesquisa
1.
Impact of temperature on the affinity of SARS-CoV-2 Spike glycoprotein for host ACE2.
J Biol Chem
; 297(4): 101151, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34478710
2.
Reduced Susceptibility to Neuraminidase Inhibitors in Influenza B Isolate, Canada.
Emerg Infect Dis
; 25(4): 838-840, 2019 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30882323
3.
The combination of oseltamivir with azithromycin does not show additional benefits over oseltamivir monotherapy in mice infected with influenza A(H1N1)pdm2009 virus.
J Med Virol
; 89(12): 2239-2243, 2017 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-28792077
4.
Influenza A(H1N1)pdm09 Virus but Not Respiratory Syncytial Virus Interferes with SARS-CoV-2 Replication during Sequential Infections in Human Nasal Epithelial Cells.
Viruses
; 14(2)2022 02 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-35215988
5.
Delivery of CRISPR-Cas systems using phage-based vectors.
Curr Opin Biotechnol
; 68: 174-180, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33360715
6.
Impact of temperature on the affinity of SARS-CoV-2 Spike for ACE2.
bioRxiv
; 2021 Jul 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34268505
7.
Characterization of contemporary influenza B recombinant viruses harboring mutations of reduced susceptibility to baloxavir marboxil, in vitro and in mice.
Antiviral Res
; 179: 104807, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32343991
8.
The Val430Ile neuraminidase (NA) substitution, identified in influenza B virus isolates, impacts the catalytic 116Arg residue causing reduced susceptibility to NA inhibitors.
Antiviral Res
; 170: 104561, 2019 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31323237
9.
Molecular pathway of influenza pan-neuraminidase inhibitor resistance in an immunocompromised patient.
Antivir Ther
; 24(8): 581-587, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-32031540
10.
In Vitro Properties and Virulence of Contemporary Recombinant Influenza B Viruses Harboring Mutations of Cross-Resistance to Neuraminidase Inhibitors.
Viruses
; 11(1)2018 12 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-30583488
11.
Impact of R152K and R368K neuraminidase catalytic substitutions on in vitro properties and virulence of recombinant A(H1N1)pdm09 viruses.
Antiviral Res
; 154: 110-115, 2018 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-29674164
12.
Comparison of early and recent influenza A(H1N1)pdm09 isolates harboring or not the H275Y neuraminidase mutation, in vitro and in animal models.
Antiviral Res
; 159: 26-34, 2018 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30219318
13.
Peramivir susceptibilities of recombinant influenza A and B variants selected with various neuraminidase inhibitors.
Antivir Ther
; 22(8): 711-716, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-29082897
14.
The I427T neuraminidase (NA) substitution, located outside the NA active site of an influenza A(H1N1)pdm09 variant with reduced susceptibility to NA inhibitors, alters NA properties and impairs viral fitness.
Antiviral Res
; 137: 6-13, 2017 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27838351
15.
The E119D neuraminidase mutation identified in a multidrug-resistant influenza A(H1N1)pdm09 isolate severely alters viral fitness in vitro and in animal models.
Antiviral Res
; 132: 6-12, 2016 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-27185624